Glaucoma is an irreversible progressive optic neuropathy, for which the major proven
treatment is to lower the intraocular pressure (IOP). Five groups of IOP‐lowering eye drops …

There is a large body of evidence from experimental and clinical studies showing that the
long-term use of topical drugs may induce ocular surface changes, causing ocular …

Background Primary open angle glaucoma (POAG) is a chronic, progressive ocular disease
causing loss of the optic nerve rim and retinal nerve fiber layer (RNFL) with associated …

Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy in adults
in which there is a characteristic acquired atrophy of the optic nerve and loss of retinal …

Background Treatments for open-angle glaucoma aim to prevent vision loss through
lowering of intraocular pressure, but to our knowledge no placebo-controlled trials have …

Glaucoma is the leading cause of irreversible blindness globally. Despite its gravity, the
disease is frequently undiagnosed in the community. Raised intraocular pressure (IOP) is …

Elevated intraocular pressure (IOP) is an important risk factor in developing glaucoma, and
variability in IOP might herald glaucomatous development or progression. We report the …

Primary open-angle glaucoma (POAG), the most common optic neuropathy, is a heritable
disease. Siblings of POAG cases have a ten-fold increased risk of developing the disease …

Antiglaucoma medications are often associated with ocular adverse reactions such as dry
eye, and burning or stinging sensations. These undesirable effects may lead to treatment …

Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern® Guidelines Page 1 P112
Primary Open-Angle Glaucoma Suspect © 2016 by the American Academy of Ophthalmology …